1. Home
  2. PFE vs BX Comparison

PFE vs BX Comparison

Compare PFE & BX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pfizer Inc.

PFE

Pfizer Inc.

HOLD

Current Price

$24.19

Market Cap

147.6B

Sector

Health Care

ML Signal

HOLD

Logo Blackstone Inc.

BX

Blackstone Inc.

HOLD

Current Price

$115.12

Market Cap

150.0B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PFE
BX
Founded
1849
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
147.6B
150.0B
IPO Year
2013
2007

Fundamental Metrics

Financial Performance
Metric
PFE
BX
Price
$24.19
$115.12
Analyst Decision
Buy
Buy
Analyst Count
14
17
Target Price
$29.29
$156.53
AVG Volume (30 Days)
32.6M
4.7M
Earning Date
05-05-2026
04-23-2026
Dividend Yield
6.55%
3.96%
EPS Growth
N/A
6.91
EPS
0.47
0.83
Revenue
$62,579,000,000.00
$14,450,265,000.00
Revenue This Year
N/A
$12.40
Revenue Next Year
N/A
$23.10
P/E Ratio
$50.29
$137.43
Revenue Growth
N/A
9.22
52 Week Low
$23.11
$101.73
52 Week High
$28.75
$190.09

Technical Indicators

Market Signals
Indicator
PFE
BX
Relative Strength Index (RSI) 34.50 43.81
Support Level $24.02 $112.70
Resistance Level $26.42 $118.16
Average True Range (ATR) 0.56 4.32
MACD -0.19 -0.72
Stochastic Oscillator 19.86 17.96

Price Performance

Historical Comparison
PFE
BX

About PFE Pfizer Inc.

Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.

About BX Blackstone Inc.

Blackstone is the world's largest alternative-asset manager with $1.304 trillion in total assets under management, including $937.6 billion in fee-earning assets under management, at the end of March 2026. The company operates with scale in each of its major product lines: private equity (27% of fee-earning AUM and 34% of base management fees), real estate/real assets (30% and 33%), credit and insurance (33% and 26%), and other alternatives (10% and 7%). While the firm primarily serves institutional investors (84% of AUM), it also caters to clients in the high-net-worth channel (16%). Blackstone operates through 25 offices in the Americas (8), Europe and the Middle East (9), and the Asia-Pacific region (8).

Share on Social Networks: